Hyperammonemia accelerates the consumption of BCAA during glutamine synthesis, which is the metabolic pathway of ammonia in skeletal muscles, causing a decrease in BCAA [22, 23], with BCAA deficiency in turn inducing an amino acid imbalance, which leads to a reduction in protein synthesis capacity [22, 23]. The gene discussed is ARID4B; the disease is Hyperammonemia.